ConvaTec appints two corporate brokers
January 16, 2017ConvaTec Group, a UK-based medical products and technologies company, said on Monday that it has appointed two joint corporate brokers.
The appointment of Goldman Sachs International and UBS Investment Bank is effective immediately.
The company that focuses on focused on therapies for the management of chronic conditions, also work with pharmaceutical companies.
It is working on infusion sets for continuous subcutaneous drug delivery for other diseases, including apomorphine for Parkinson’s disease, immunoglobulins for primary immunodeficiencies and thalassaemia and morphine for palliative pain management.
